A survey of antibiotic administration practices involving patients with sepsis in UK critical care units

被引:10
作者
Barton, Gregory J. [1 ]
Morecroft, Charles W. [1 ]
Henney, Neil C. [1 ]
机构
[1] Liverpool John Moores Univ, Pharm & Biomol Sci, Liverpool, Merseyside, England
关键词
Antibiotic administration; Clinical outcome; Critical care; Critical care pharmacist; Sepsis; Therapeutic drug monitoring; United Kingdom; BETA-LACTAM ANTIBIOTICS; CONTINUOUS-INFUSION; PIPERACILLIN-TAZOBACTAM; PSEUDOMONAS-AERUGINOSA; INTERMITTENT INFUSION; ILL PATIENTS; ANTIMICROBIAL RESISTANCE; VANCOMYCIN; OUTCOMES; SUFFICIENT;
D O I
10.1007/s11096-019-00938-9
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background Alternative administration methods are emerging as a key area of research to improve clinical efficacy of antibiotics and address concerns regarding multi-drug resistance. Extended intermittent infusions or continuous infusions of antibiotics exhibiting time-dependent kill characteristics may be favourable in critically ill septic patients, but more evidence is needed to determine best practice. Objective To find out whether any common practice exists for intravenous antibiotic administration in critical care units across UK NHS Trusts, and identify factors influencing the adoption of extended or continuous infusions. Setting UK hospitals. Method UK critical care pharmacists were invited to participate in a survey on behalf of all 240 critical care units via a UK Clinical Pharmacy Association message board. The survey focused on administration practices for 22 antibacterial agents. Main outcome measure Antibiotic administration method. Results Responses were received covering 64 units, a response rate of 26.2%. Common, but not uniform administration methods were apparent for 17/22 antibiotics. Four antibiotics (piperacillin/tazobactam, doripenem, meropenem and vancomycin) were more likely to be administered as continuous or extended-intermittent infusions. Choice of administration method was especially influenced by altered pk/pd properties in sepsis or severe burns patients, or by the presence of organisms requiring high minimal inhibitory concentrations. Conclusion Unlicensed alternative practices of antibiotic administration are widespread but only weak evidence exists of any patient benefit, such as reduced length of stay in critical care, and none showing improvement in mortality. Further research is needed to determine whether extended infusion methods offer clinically meaningful advantages over shorter licenced administration methods in patients in critical care units.
引用
收藏
页码:65 / 71
页数:7
相关论文
共 30 条
  • [1] Applying Pharmacokinetic/Pharmacodynamic Principles in Critically Ill Patients: Optimizing Efficacy and Reducing Resistance Development
    Abdul-Aziz, Mohd H.
    Lipman, Jeffrey
    Mouton, Johan W.
    Hope, William W.
    Roberts, Jason A.
    [J]. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 36 (01) : 136 - 153
  • [2] Continuous beta-lactam infusion in critically ill patients: the clinical evidence
    Abdul-Aziz, Mohd H.
    Dulhunty, Joel M.
    Bellomo, Rinaldo
    Lipman, Jeffrey
    Roberts, Jason A.
    [J]. ANNALS OF INTENSIVE CARE, 2012, 2
  • [3] Clinical and microbiological efficacy of continuous versus intermittent application of meropenem in critically ill patients: a randomized open-label controlled trial
    Chytra, Ivan
    Stepan, Martin
    Benes, Jan
    Pelnar, Petr
    Zidkova, Alexandra
    Bergerova, Tamara
    Pradl, Richard
    Kasal, Eduard
    [J]. CRITICAL CARE, 2012, 16 (03):
  • [4] Risk factors for target non-attainment during empirical treatment with β-lactam antibiotics in critically ill patients
    De Waele, Jan J.
    Lipman, J.
    Akova, M.
    Bassetti, M.
    Dimopoulos, G.
    Kaukonen, M.
    Koulenti, D.
    Martin, C.
    Montravers, P.
    Rello, J.
    Rhodes, A.
    Udy, A. A.
    Starr, T.
    Wallis, S. C.
    Roberts, J. A.
    [J]. INTENSIVE CARE MEDICINE, 2014, 40 (09) : 1340 - 1351
  • [5] Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI DOI 10.1007/s00134-012-2769-8
  • [6] A Multicenter Randomized Trial of Continuous versus Intermittent β-Lactam Infusion in Severe Sepsis
    Dulhunty, Joel M.
    Roberts, Jason A.
    Davis, Joshua S.
    Webb, Steven A. R.
    Bellomo, Rinaldo
    Gomersall, Charles
    Shirwadkar, Charudatt
    Eastwood, Glenn M.
    Myburgh, John
    Paterson, David L.
    Starr, Therese
    Paul, Sanjoy K.
    Lipman, Jeffrey
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 192 (11) : 1298 - 1305
  • [7] Continuous Infusion of Beta-Lactam Antibiotics in Severe Sepsis: A Multicenter Double-Blind, Randomized Controlled Trial
    Dulhunty, Joel M.
    Roberts, Jason A.
    Davis, Joshua S.
    Webb, Steven A. R.
    Bellomo, Rinaldo
    Gomersall, Charles
    Shirwadkar, Charudatt
    Eastwood, Glenn M.
    Myburgh, John
    Paterson, David L.
    Lipman, Jeffrey
    [J]. CLINICAL INFECTIOUS DISEASES, 2013, 56 (02) : 236 - 244
  • [8] EMA, 2011, EMEAHA30001149
  • [9] Impact of Bolus Dosing versus Continuous Infusion of Piperacillin and Tazobactam on the Development of Antimicrobial Resistance in Pseudomonas aeruginosa
    Felton, T. W.
    Goodwin, J.
    O'Connor, L.
    Sharp, A.
    Gregson, L.
    Livermore, J.
    Howard, S. J.
    Neely, M. N.
    Hope, W. W.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (12) : 5811 - 5819
  • [10] Clinical efficacy and pharmacoeconomics of a continuous-infusion piperacillin-tazobactam program in a large community teaching hospital
    Grant, EM
    Kuti, JL
    Nicolau, DP
    Nightingale, C
    Quintiliani, R
    [J]. PHARMACOTHERAPY, 2002, 22 (04): : 471 - 483